Nutex Health Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Nutex Health stock have an average target of 250, with a low estimate of 175 and a high estimate of 300. The average target predicts an increase of 47.93% from the current stock price of 169.00.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$175	$250	$290	$300
Change	+3.55%	+47.93%	+71.60%	+77.51%

Analyst Ratings

The average analyst rating for Nutex Health stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Nov '25	Dec '25	Mar '26	May '26	Jun '26
Strong Buy	2	2	2	2	2	3
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anderson Schock B. Riley Securities	B. Riley Securities	Buy Initiates $290	Buy	Initiates	$290	+71.60%	Jun 26, 2026
Ben Haynor Lake Street	Lake Street	Buy Initiates $235	Buy	Initiates	$235	+39.05%	Jun 2, 2026
Anthony Vendetti Maxim Group	Maxim Group	Buy Maintains $175	Buy	Maintains	$175	+3.55%	May 3, 2026
Bill Sutherland Benchmark Co.	Benchmark Co.	Buy Reiterates $300	Buy	Reiterates	$300	+77.51%	Mar 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

881.34M

from 875.26M

0.70%

from 875.26M

Revenue Next Year

972.16M

from 881.34M

10.30%

from 881.34M

EPS This Year

19.59

from -

EPS Next Year

20.33

from 19.59

3.78%

from 19.59

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	331.53M	219.29M	247.65M	479.95M	875.26M	881.34M	972.16M
Revenue Growth	20.98%	-33.85%	12.93%	93.80%	82.37%	0.70%	10.30%
EPS	33.00	-100.36	-10.39	9.69	10.48	21.22	22.75
EPS Growth	23.07%	-	-	-	8.13%	102.48%	7.22%
Forward PE	-	-	-	-	-	7.96	7.43
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	908.7M	1.0B
Avg	881.3M	972.2M
Low	865.0M	949.3M

Revenue Growth

Revenue Growth	2026	2027
High	3.8%	14.0%
Avg	0.7%	10.3%
Low	-1.2%	7.7%

EPS Forecast

EPS	2026	2027
High	19.59	20.33
Avg	19.59	20.33
Low	19.59	20.33

EPS Growth

EPS Growth	2027	2028
High	3.8%	-
Avg	3.8%	-
Low	3.8%	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.